$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
短短8个月,COVID-19抗体鸡尾酒疗法将感染风险降低了82%
2025-10-19 11:44:20
Check Details
默沙东新冠“特效药”莫努匹韦(Molnupiravir)引发关注!疗效如何?
2025-10-19 11:44:20
Check Details
CHMP建议批准Ronapreve用于预防和治疗COVID-19
2025-10-19 11:44:20
Check Details
肌肉注射sotrovimab用于COVID-19早期治疗,达到了试验的主要终点
2025-10-19 11:44:20
Check Details
辉瑞寻求新型COVID-19口服药PAXLOVID的紧急使用授权
2025-10-19 11:44:20
Check Details
SSRIs与降低COVID-19死亡率的相对风险有关
2025-10-19 11:44:20
Check Details
花费10亿美元!美国政府出资购买COVID-19治疗药物sotrovimab
2025-10-19 11:44:20
Check Details
LOKELMA®在美国获得快速通道认证,以改善慢性血液透析伴高钾血症患者的心血管结局
2025-10-19 11:44:20
Check Details
研究发现,COVID-19会增加妊娠期间的死胎风险
2025-10-19 11:44:20
Check Details
首款治疗重症新冠感染药物:以色列MesenCure显示出良好前景
2025-10-19 11:44:20
Check Details
注意!新冠病毒新变体,奥密克戎(Omicron )
2025-10-19 11:44:20
Check Details
全球首款新冠口服药莫努匹韦在天津怎么购买?
2025-10-19 11:44:20
Check Details
1
2
...
3422
3423
3424
3425
3426
3427
3428
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Key points for drug monitoring of Molotinib in bone marrow fibrosis
2
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
3
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
4
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
5
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
6
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
7
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
8
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
9
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
10
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
11
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
12
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL